Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era

G Goyal, ML Heaney, M Collin… - Blood, The Journal …, 2020 - ashpublications.org
Erdheim-Chester disease (ECD) is a rare histiocytosis that was recently recognized as a
neoplastic disorder owing to the discovery of recurrent activating MAPK (RAS-RAF-MEK …

Histiocytic disorders

KL McClain, C Bigenwald, M Collin… - Nature Reviews …, 2021 - nature.com
The historic term 'histiocytosis' meaning 'tissue cell'is used as a unifying concept for
diseases characterized by pathogenic myeloid cells that share histological features with …

ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition

PG Kemps, J Picarsic, BH Durham… - Blood, The Journal …, 2022 - ashpublications.org
ALK-positive histiocytosis is a rare subtype of histiocytic neoplasm first described in 2008 in
3 infants with multisystemic disease involving the liver and hematopoietic system. This entity …

IgG4-related disease: what a hematologist needs to know

LYC Chen, A Mattman, MA Seidman… - …, 2019 - pmc.ncbi.nlm.nih.gov
IgG4-related disease is a fibro-inflammatory condition that can affect nearly any organ
system. Common presentations include major salivary and lacrimal gland enlargement …

[HTML][HTML] The histopathology of Erdheim–Chester disease: a comprehensive review of a molecularly characterized cohort

N Ozkaya, MK Rosenblum, BH Durham, JD Pichardo… - Modern Pathology, 2018 - Elsevier
Erdheim–Chester disease is a rare, non-Langerhans cell histiocytosis histologically
characterized by multi-systemic proliferation of mature histiocytes in a background of …

The Mayo Clinic Histiocytosis Working Group consensus statement for the diagnosis and evaluation of adult patients with histiocytic neoplasms: Erdheim-Chester …

G Goyal, JR Young, MJ Koster, WO Tobin… - Mayo Clinic …, 2019 - Elsevier
Histiocytic neoplasms, a rare and heterogeneous group of disorders, primarily include
Erdheim-Chester disease, Langerhans cell histiocytosis, and Rosai-Dorfman disease. Due …

Imaging in Erdheim-Chester Disease

Y Aswani, A Patel, X Zhan, S Ansari, LG Marcelino… - Radiographics, 2024 - pubs.rsna.org
Erdheim-Chester disease (ECD) is a rare, multisystemic, inflammatory, non–Langerhans cell
histiocytic neoplasm. The discovery of recurrent and somatic mutations in the mitogen …

Erdheim-chester disease

J Haroche, F Cohen-Aubart… - Blood, The Journal of the …, 2020 - ashpublications.org
Erdheim-Chester disease (ECD) is characterized by the infiltration of tissues by foamy
CD68+ CD1a− histiocytes, with 1500 known cases since 1930. Mutations activating the …

Histiocytic neoplasms, version 2.2021, NCCN clinical practice guidelines in oncology

RS Go, E Jacobsen, R Baiocchi, I Buhtoiarov… - Journal of the National …, 2021 - jnccn.org
Histiocytic neoplasms are rare hematologic disorders accounting for less than 1% of cancers
of the soft tissue and lymph nodes. Clinical presentation and prognosis of these disorders …

Histiocytosis and the nervous system: from diagnosis to targeted therapies

F Cohen Aubart, A Idbaih, JF Emile, Z Amoura… - Neuro …, 2021 - academic.oup.com
Histiocytoses are heterogeneous hematopoietic diseases characterized by the accumulation
of CD68 (+) cells with various admixed inflammatory infiltrates. The identification of the …